Lessons Learned: Santhera Will Refile Raxone For DMD In EU Next Year

 
• By Lucie Ellis-Taitt
  
Dominos
CHMP setback: Santhera will regroup and try again with DMD drug in 2019 • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Pink Sheet